ACEA S.p.A. (BIT:ACE)
Italy · Delayed Price · Currency is EUR | Market Cap | 4.47B +4.8% |
| Revenue (ttm) | 2.83B -31.8% |
| Net Income | 708.42M +83.3% |
| EPS | n/a |
| Shares Out | 212.55M |
| PE Ratio | 6.31 |
| Forward PE | 13.37 |
| Dividend | 0.95 (4.51%) |
| Ex-Dividend Date | Jun 22, 2026 |
| Volume | 104,168 |
| Open | 21.06 |
| Previous Close | 21.06 |
| Day's Range | 20.94 - 21.16 |
| 52-Week Range | 19.01 - 26.52 |
| Beta | 0.89 |
| Analysts | Strong Buy |
| Price Target | 26.33 (+25.14%) |
| Earnings Date | Nov 13, 2026 |
About ACEA S.p.A.
ACEA S.p.A., together with its subsidiaries, operates as a multi-utility company in Italy. The company operates through Environment, Commercial, Water, Water (Overseas), Production, Engineering & Infrastructure Projects, and Network & Public Lighting segments. It is involved in the waste management, power generation, water management, energy distribution and production, gas distribution, management of engineering services, and sale of electricity and natural gas, as well as supplies value added environmental services. The company also generates... [Read more]
Financial Performance
In 2025, ACEA S.p.A.'s revenue was 2.76 billion, an increase of 0.29% compared to the previous year's 2.75 billion. Earnings were 480.58 million, an increase of 44.92%.
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for ACE stock is "Strong Buy." The 12-month stock price target is €26.33, which is an increase of 25.14% from the latest price.
News
DCA raids med shops for violations over sale of weight-loss drugs
Telangana DCA raids 43 medical shops over illegal sales of weight-loss drugs like Ozempic and Mounjaro; notices issued, action under Drugs and Cosmetics Act.
DCA row deepens after removal of executive members, fresh election demand grows
Dhanbad Cricket Association row deepens after removal of two executive members, sparking constitutional dispute, transparency concerns and calls for fresh elections.
ACEA S.p.A. Earnings Call Transcript: Q2 2026
EBITDA and net profit saw strong year-over-year growth, driven by regulated businesses and a major capital gain from the ACEA Energia sale. CapEx remained focused on regulated assets, and management expects to reach the high end of 2026 guidance, with further acceleration in H2.
ACEA S.p.A. Earnings release: Q2 2026
ACEA S.p.A. released its Q2 2026 earnings on July 23, 2026, summarizing the period's financial results.
ACEA S.p.A. Slides: Q2 2026
ACEA S.p.A. has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 23, 2026.
DCA busts unlicensed shop, seizes meds worth Rs 18,000
Telangana DCA raids unlicensed Chandrayangutta medical outlet, seizes Rs 18,000 in antibiotics and other drugs; samples sent for analysis, legal action planned.
DCA raids quack’s clinic, seizes medicines
Telangana DCA raid in Khammam seizes 11 illegal medicines worth Rs 10,000 from unqualified practitioner; antibiotics raise antimicrobial resistance concerns.
ACEA S.p.A. Slides: Investor presentation
ACEA S.p.A. has posted slides in relation to its latest quarterly earnings report, which was published on June 8, 2026.
ACEA S.p.A. Earnings Call Transcript: Q1 2026
Q1 2026 saw strong growth in regulated businesses, with EBITDA up 4% and net income up 14% year-over-year. CapEx rose 18%, and guidance for 2026 is confirmed, supported by stable financials and ongoing investment in infrastructure.
ACEA S.p.A. Earnings release: Q1 2026
ACEA S.p.A. released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
ACEA S.p.A. Slides: Q1 2026
ACEA S.p.A. has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 14, 2026.
ACEA S.p.A. Quarterly report: Q1 2026
ACEA S.p.A. has published its Q1 2026 quarterly earnings report on May 14, 2026.
ACEA S.p.A. Slides: Investor presentation
ACEA S.p.A. has posted slides in relation to its latest quarterly earnings report, which was published on March 25, 2026.
ACEA S.p.A. Slides: Investor presentation
ACEA S.p.A. has posted slides in relation to its latest quarterly earnings report, which was published on March 13, 2026.
ACEA S.p.A. Earnings Call Transcript: Q4 2025
Record 2025 results with EBITDA up 10% and net profit up 49% year-over-year, driven by asset rotation, strong regulated business focus, and operational efficiency. Dividend rises 26% to €1.20 per share, including a one-off from asset disposals.
ACEA S.p.A. Earnings release: Q4 2025
ACEA S.p.A. released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
ACEA S.p.A. Slides: Q4 2025
ACEA S.p.A. has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.
ACEA S.p.A. Annual report: Q4 2025
ACEA S.p.A. has published its Q4 2025 annual report on March 12, 2026.
ACEA S.p.A. Slides: Investor presentation
ACEA S.p.A. has posted slides in relation to its latest quarterly earnings report, which was published on November 26, 2025.
ACEA S.p.A. Earnings Call Transcript: Q3 2025
Strong growth in EBITDA and net profit for the first nine months of 2025, driven by regulated businesses and asset disposals. 2025 guidance was raised, with stable financial ratios and a focus on core water, grid, and environment segments.
ACEA S.p.A. Earnings release: Q3 2025
ACEA S.p.A. released its Q3 2025 earnings on November 13, 2025, summarizing the period's financial results.
ACEA S.p.A. Slides: Q3 2025
ACEA S.p.A. has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 13, 2025.
ACEA S.p.A. Quarterly report: Q3 2025
ACEA S.p.A. has published its Q3 2025 quarterly earnings report on November 13, 2025.
ACEA S.p.A. Slides: Investor presentation
ACEA S.p.A. has posted slides in relation to its latest quarterly earnings report, which was published on September 10, 2025.